Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules
Open Access
- 3 November 2009
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 7 (1) , 67
Abstract
Tuberculosis contributes significantly to morbidity and mortality among HIV-infected children in sub-Saharan Africa. Isoniazid prophylaxis can reduce tuberculosis incidence in this population. However, for the treatment to be effective, adherence to the medication must be optimized. We investigated adherence to isoniazid prophylaxis administered daily, compared to three times a week, and predictors of adherence amongst HIV-infected children.Keywords
This publication has 42 references indexed in Scilit:
- Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort studyBMC Pediatrics, 2008
- Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative ResearchPLOS Medicine, 2007
- Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South AfricaBMC Pediatrics, 2007
- Practical and Conceptual Challenges in Measuring Antiretroviral AdherenceJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trialBMJ, 2006
- Adherence to isoniazid preventive chemotherapy: a prospective community based studyArchives of Disease in Childhood, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- Treatment of latent tuberculosis infection in HIV infected persons2004
- Cotrimoxazole prophylaxis for opportunistic infections in adults with HIVCochrane Database of Systematic Reviews, 2003
- Analysis of Longitudinal DataTechnometrics, 1995